New hope for tough lung cancers: Triple-Threat treatment tested
NCT ID NCT04340882
Summary
This study is testing a new combination of three drugs for people with advanced non-small cell lung cancer that has spread or come back after standard treatments failed. The goal is to see if mixing an immunotherapy drug, a drug that blocks tumor blood supply, and a chemotherapy is safe and can better control the cancer's growth. It is for patients whose cancer got worse despite prior treatment with platinum-based chemotherapy and immunotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IV LUNG CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Grady Health System
Atlanta, Georgia, 30303, United States
-
Winship Cancer Institute of Emory University
Atlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.